Menu
Recruiting NCT06374355

Semibranch Registry - Retrospective

— Observational Aortic Aneurysm Endovascular Aortic Repair Stent-Graft Endoleak

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Semibranch CMD branched aortic stentgraft.
Who it may be relevant to
Registry conditions: Aortic Aneurysm, Endovascular Aortic Repair, Stent-Graft Endoleak. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Retrospective, Multicentre Registry

Overview

The goal of this registry is to evaluate the semibranch in branched endovascular arotic repair, which is a new tool in endovascular branched aortic repair.

Detailed description

The main question it aims to answer are:

* Patency of the semibranch * Feasibility of the technique regarding cannulation and stentgrafting

Interventions

  • Device Semibranch CMD branched aortic stentgraft
    bEVAR with a custom made abdominal aortic multibranch, which incorporates the semibranch design

Primary outcome measures

  • Freedom from target vessel instability [Time frame: 30 days after intervention]
  • Mortality [Time frame: 30 days after intervention]
  • Technical success [Time frame: 12 hours after intervention]
Secondary outcome measures (4)
  • Morbidity [Time frame: During follow up period (up to 3 years)]
  • Freedom of Endoleak type I and III [Time frame: During follow up period (up to 3 years)]
  • Long term mortality [Time frame: During follow up period (up to 3 years)]
  • Branch patency [Time frame: During follow up period (up to 3 years)]

Eligibility criteria

  • Patient has been treated with the semibranch stentgraft
  • Patient is over 18 years old

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Germany · 1 center
  • Muenster University Hospital — Münster

Identifiers

NCT: NCT06374355 · Semibranch_Retro

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗